ATUM

Last updated
ATUM
Company typePrivate
Industry Biotechnology
Founded2003
FoundersSridhar Govindarajan, Claes Gustafsson, Jeremy Minshull, Jon Ness
Headquarters,
Products Artificial gene synthesis, protein engineering, protein production, bioinformatics, cell line development, transposases

ATUM is an American biotechnology company. ATUM provides tools for the design and synthesis of optimized DNA, as well as protein production and GMP cell line development.

Contents

The company

ATUM (formerly DNA2.0) was founded in 2003, in Menlo Park, California. The company is privately held [1] and continues to have all research, development and production in California, currently in their 50,000 sq ft Newark facility. [2] It began and continues as a gene synthesis and protein engineering provider to academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. Gene synthesis rapidly replaced molecular cloning for many academic and corporate labs, as "foundries for the biotechnology age" allowing made-to-order genes for biological research. [3]

DNA2.0 was featured on the PBS show Nova ScienceNow [4] to show how genes are created synthetically in a lab. In 2008, the company supplied some of the DNA stretches used to create a synthetic bacterial genome. [5]

Dan Rather Reports included DNA2.0 in their episode on synthetic biology [6] and how the field is solving "some of the most important problems facing the world." [6]

In 2009, The Scientist named the codon design algorithms [7] (now trademarked as GeneGPS) developed by DNA2.0 as one of the "Top 10 Innovations" of the year for life sciences. [8] ATUM developed the Electra Vector System, a universal cloning system that utilizes the type IIS restriction enzyme SapI and T4 DNA ligase in a single-tube reaction. [9] ATUM has made some molecular components, such as synthetic fluorescent proteins, available in open-access collections of DNA parts (BioBricks Foundation). [10] Atum is a founding member of the International Gene Synthesis Consortium (IGSC) to promote biosecurity in the gene-synthesis industry. [11] [12] There are over 1,200 [13] published scientific articles using DNA2.0 products and/or services, of which 44 [14] include company employees as authors.

Research tools

Partnerships

Related Research Articles

<span class="mw-page-title-main">Complementary DNA</span> DNA reverse transcribed from RNA

In genetics, complementary DNA (cDNA) is DNA that was reverse transcribed from an RNA. cDNA exists in both single-stranded and double-stranded forms and in both natural and engineered forms.

<span class="mw-page-title-main">Plasmid</span> Small DNA molecule within a cell

A plasmid is a small, extrachromosomal DNA molecule within a cell that is physically separated from chromosomal DNA and can replicate independently. They are most commonly found as small circular, double-stranded DNA molecules in bacteria; however, plasmids are sometimes present in archaea and eukaryotic organisms. In nature, plasmids often carry genes that benefit the survival of the organism and confer selective advantage such as antibiotic resistance. While chromosomes are large and contain all the essential genetic information for living under normal conditions, plasmids are usually very small and contain only additional genes that may be useful in certain situations or conditions. Artificial plasmids are widely used as vectors in molecular cloning, serving to drive the replication of recombinant DNA sequences within host organisms. In the laboratory, plasmids may be introduced into a cell via transformation. Synthetic plasmids are available for procurement over the internet.

<span class="mw-page-title-main">Expression vector</span> Virus or plasmid designed for gene expression in cells

An expression vector, otherwise known as an expression construct, is usually a plasmid or virus designed for gene expression in cells. The vector is used to introduce a specific gene into a target cell, and can commandeer the cell's mechanism for protein synthesis to produce the protein encoded by the gene. Expression vectors are the basic tools in biotechnology for the production of proteins.

<span class="mw-page-title-main">Library (biology)</span> Collection of genetic material fragments

In molecular biology, a library is a collection of genetic material fragments that are stored and propagated in a population of microbes through the process of molecular cloning. There are different types of DNA libraries, including cDNA libraries, genomic libraries and randomized mutant libraries. DNA library technology is a mainstay of current molecular biology, genetic engineering, and protein engineering, and the applications of these libraries depend on the source of the original DNA fragments. There are differences in the cloning vectors and techniques used in library preparation, but in general each DNA fragment is uniquely inserted into a cloning vector and the pool of recombinant DNA molecules is then transferred into a population of bacteria or yeast such that each organism contains on average one construct. As the population of organisms is grown in culture, the DNA molecules contained within them are copied and propagated.

<span class="mw-page-title-main">Synthetic biology</span> Interdisciplinary branch of biology and engineering

Synthetic biology (SynBio) is a multidisciplinary field of science that focuses on living systems and organisms, and it applies engineering principles to develop new biological parts, devices, and systems or to redesign existing systems found in nature.

<span class="mw-page-title-main">Recombinant DNA</span> DNA molecules formed by human agency at a molecular level generating novel DNA sequences

Recombinant DNA (rDNA) molecules are DNA molecules formed by laboratory methods of genetic recombination that bring together genetic material from multiple sources, creating sequences that would not otherwise be found in the genome.

A DNA construct is an artificially-designed segment of DNA borne on a vector that can be used to incorporate genetic material into a target tissue or cell. A DNA construct contains a DNA insert, called a transgene, delivered via a transformation vector which allows the insert sequence to be replicated and/or expressed in the target cell. This gene can be cloned from a naturally occurring gene, or synthetically constructed. The vector can be delivered using physical, chemical or viral methods. Typically, the vectors used in DNA constructs contain an origin of replication, a multiple cloning site, and a selectable marker. Certain vectors can carry additional regulatory elements based on the expression system involved.

This page provides an alphabetical list of articles and other pages about biotechnology.

Steven Albert Benner is an American chemist. He has been a professor at Harvard University, ETH Zurich, and most recently at the University of Florida, where he was the V.T. & Louise Jackson Distinguished Professor of Chemistry. In 2005, he founded The Westheimer Institute of Science and Technology (TWIST) and the Foundation For Applied Molecular Evolution. Benner has also founded the companies EraGen Biosciences and Firebird BioMolecular Sciences LLC.

<span class="mw-page-title-main">DNA shuffling</span>

DNA shuffling, also known as molecular breeding, is an in vitro random recombination method to generate mutant genes for directed evolution and to enable a rapid increase in DNA library size. Three procedures for accomplishing DNA shuffling are molecular breeding which relies on homologous recombination or the similarity of the DNA sequences, restriction enzymes which rely on common restriction sites, and nonhomologous random recombination which requires the use of hairpins. In all of these techniques, the parent genes are fragmented and then recombined.

<span class="mw-page-title-main">Gene delivery</span> Introduction of foreign genetic material into host cells

Gene delivery is the process of introducing foreign genetic material, such as DNA or RNA, into host cells. Gene delivery must reach the genome of the host cell to induce gene expression. Successful gene delivery requires the foreign gene delivery to remain stable within the host cell and can either integrate into the genome or replicate independently of it. This requires foreign DNA to be synthesized as part of a vector, which is designed to enter the desired host cell and deliver the transgene to that cell's genome. Vectors utilized as the method for gene delivery can be divided into two categories, recombinant viruses and synthetic vectors.

Synthetic genomics is a nascent field of synthetic biology that uses aspects of genetic modification on pre-existing life forms, or artificial gene synthesis to create new DNA or entire lifeforms.

Artificial gene synthesis, or simply gene synthesis, refers to a group of methods that are used in synthetic biology to construct and assemble genes from nucleotides de novo. Unlike DNA synthesis in living cells, artificial gene synthesis does not require template DNA, allowing virtually any DNA sequence to be synthesized in the laboratory. It comprises two main steps, the first of which is solid-phase DNA synthesis, sometimes known as DNA printing. This produces oligonucleotide fragments that are generally under 200 base pairs. The second step then involves connecting these oligonucleotide fragments using various DNA assembly methods. Because artificial gene synthesis does not require template DNA, it is theoretically possible to make a completely synthetic DNA molecule with no limits on the nucleotide sequence or size.

<span class="mw-page-title-main">Christopher Voigt</span> American bioengineer

Christopher Voigt is an American synthetic biologist, molecular biophysicist, and engineer.

<span class="mw-page-title-main">Gene Designer</span>

Gene Designer is a computer software package for bioinformatics. It is used by molecular biologists from academia, government, and the pharmaceutical, chemical, agricultural, and biotechnology industries to design, clone, and validate genetic sequences. It is proprietary software, released as freeware needing registration.

<span class="mw-page-title-main">Molecular cloning</span> Set of methods in molecular biology

Molecular cloning is a set of experimental methods in molecular biology that are used to assemble recombinant DNA molecules and to direct their replication within host organisms. The use of the word cloning refers to the fact that the method involves the replication of one molecule to produce a population of cells with identical DNA molecules. Molecular cloning generally uses DNA sequences from two different organisms: the species that is the source of the DNA to be cloned, and the species that will serve as the living host for replication of the recombinant DNA. Molecular cloning methods are central to many contemporary areas of modern biology and medicine.

<span class="mw-page-title-main">Synthetic biological circuit</span>

Synthetic biological circuits are an application of synthetic biology where biological parts inside a cell are designed to perform logical functions mimicking those observed in electronic circuits. Typically, these circuits are categorized as either genetic circuits, RNA circuits, or protein circuits, depending on the types of biomolecule that interact to create the circuit's behavior. The applications of all three types of circuit range from simply inducing production to adding a measurable element, like green fluorescent protein, to an existing natural biological circuit, to implementing completely new systems of many parts.

<span class="mw-page-title-main">Genetic engineering techniques</span> Methods used to change the DNA of organisms

Genetic engineering techniques allow the modification of animal and plant genomes. Techniques have been devised to insert, delete, and modify DNA at multiple levels, ranging from a specific base pair in a specific gene to entire genes. There are a number of steps that are followed before a genetically modified organism (GMO) is created. Genetic engineers must first choose what gene they wish to insert, modify, or delete. The gene must then be isolated and incorporated, along with other genetic elements, into a suitable vector. This vector is then used to insert the gene into the host genome, creating a transgenic or edited organism.

<span class="mw-page-title-main">Infologs</span>

Infologs are independently designed synthetic genes derived from one or a few genes where substitutions are systematically incorporated to maximize information. Infologs are designed for perfect diversity distribution to maximize search efficiency.

Transient expression, more frequently referred to "transient gene expression", is the temporary expression of genes that are expressed for a short time after nucleic acid, most frequently plasmid DNA encoding an expression cassette, has been introduced into eukaryotic cells with a chemical delivery agent like calcium phosphate (CaPi) or polyethyleneimine (PEI). However, unlike "stable expression," the foreign DNA does not fuse with the host cell DNA, resulting in the inevitable loss of the vector after several cell replication cycles. The majority of transient gene expressions are done with cultivated animal cells. The technique is also used in plant cells; however, the transfer of nucleic acids into these cells requires different methods than those with animal cells. In both plants and animals, transient expression should result in a time-limited use of transferred nucleic acids, since any long-term expression would be called "stable expression."

References

  1. Duan, Mary (October 18, 2009). "Gene synthesis: It's no strain for DNA 2.0". Silicon Valley Business Journal. San Jose, CA.
  2. "DNA2.0 Builds State of the Art Bioproduction Facility in Newark, California". MercuryNews.com. The San Jose Mercury News. Retrieved 22 March 2016.
  3. Pollack (September 12, 2007). "How Do You Like Your Genes? Biofabs Take Orders". The New York Times. New York.
  4. "Artificial Life". Nova ScienceNow . October 18, 2005. PBS.
  5. Pollack (January 24, 2008). "Scientists Take New Step Toward Man-Made Life". The New York Times. New York.
  6. 1 2 "Cutting Edge". Dan Rather Reports . April 30, 2013. AXS TV.
  7. Welch; Govindarajan; Ness; Villalobos; Gurney; Minshull; Gustafsson (September 14, 2009). "Design parameters to control synthetic gene expression in Escherichia coli". PLOS ONE. 4 (9): e7002. doi: 10.1371/journal.pone.0007002 . PMC   2736378 . PMID   19759823.
  8. "2009 Top 10 Innovations". The Scientist. 23 (12): 41–52. December 1, 2009.
  9. Whitman; Gore; Ness; Theodorou; Minshull (June 2013), "Rapid, Scarless Cloning of Gene Fragments Using SapI, T4 DNA Ligase and the DNA2.0 Electra Vector System" (PDF), NEB Expressions, II: 8
  10. Ledford, Heidi (July 4, 2013). "Bioengineers Look Beyond Patents". Nature. 499 (7456). Macmillan Publishers Limited: 16–17. doi: 10.1038/499016a . PMID   23823774.
  11. Hayden, Erika Check (November 18, 2009). "Gene-makers form security coalition". Nature. doi:10.1038/news.2009.1095.
  12. "Gene-Synthesis Firms Set Up Biosecurity Protocol", Genetic Engineering & Biotechnology News, November 18, 2009
  13. "Literature Database Search All". April 29, 2016.
  14. "Literature Database Search Author Affiliation:DNA2.0". April 29, 2016.
  15. Villalobos, Alan; Ness, Jon E; Gustafsson, Claes; Minshull, Jeremy; Govindarajan, Sridhar (2006). "Gene Designer: A synthetic biology tool for constructing artificial DNA segments". BMC Bioinformatics. 7: 285. doi: 10.1186/1471-2105-7-285 . PMC   1523223 . PMID   16756672.
  16. Villalobos, Alan; Welch, Mark; Minshull, Jeremy (2012). "In Silico Design of Functional DNA Constructs". Gene Synthesis. Methods in Molecular Biology. Vol. 852. pp. 197–213. doi:10.1007/978-1-61779-564-0_15. ISBN   978-1-61779-563-3. PMID   22328435.
  17. Welch, M; Villalobos, A; Gustafsson, C; Minshull, J (2011). Designing genes for successful protein expression. Methods in Enzymology. Vol. 498. pp. 43–66. doi:10.1016/B978-0-12-385120-8.00003-6. ISBN   9780123851208. PMID   21601673.
  18. Dance, Amber (July 1, 2012). "Mover Over, Mother Nature". The Scientist.
  19. "Best of the Web". Genetic Engineering News. April 15, 2007.
  20. "Optimizing Gene Expression with DNA2.0 Technology". GEN. November 14, 2012.
  21. McEnery, Regina (February 4, 2013), "Delivering the DNA", VAX: The Bulletin on AIDS Vaccine Research, 11 (1), archived from the original on November 29, 2014, retrieved November 19, 2014
  22. Cohen, Bryan (December 24, 2013). "DNA2.0 Announces Biopharmaceutical Partnership with St. George's". Vaccine News.
  23. "ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement". San Jose Mercury News. San Jose, CA. November 17, 2014.